Changes in Remote Monitoring for Patients With Cardiac Implantable Electronic Devices After a Reimbursement Revision　- An Interrupted Time-Series Analysis.

BACKGROUND: Remote monitoring (RM) enables early detection of abnormalities in cardiac implantable electronic devices (CIED), but implementation remains suboptimal. METHODS AND RESULTS: We analyzed 396,296 patients hospitalized for CIED implantation and evaluated changes after RM reimbursement revision using an interrupted time-series analysis. The proportion increased by 4.89% (95% confidence interval [CI]: 3.71 to 6.06%) in the pacemaker implantation cohort, but no significant increase was observed in the implantable cardioverter defibrillator and cardiac resynchronization therapy cohort (0.79%; 95% CI: -1.12 to 2.71%). CONCLUSIONS: The effect of reimbursement policy changes on RM adoption may differ according to the type of CIED.